WEBULL
WebtradeDownload

Loss-Making MiniMed Group, Inc. (NASDAQ:MMED) Set To Breakeven

Simply Wall St · 1d ago

We feel now is a pretty good time to analyse MiniMed Group, Inc.'s (NASDAQ:MMED) business as it appears the company may be on the cusp of a considerable accomplishment. MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The US$5.2b market-cap company posted a loss in its most recent financial year of US$333m and a latest trailing-twelve-month loss of US$314m shrinking the gap between loss and breakeven. As path to profitability is the topic on MiniMed Group's investors mind, we've decided to gauge market sentiment. In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

MiniMed Group is bordering on breakeven, according to the 15 American Medical Equipment analysts. They anticipate the company to incur a final loss in 2026, before generating positive profits of US$186m in 2027. Therefore, the company is expected to breakeven roughly a year from now or less! How fast will the company have to grow to reach the consensus forecasts that anticipate breakeven by 2027? Working backwards from analyst estimates, it turns out that they expect the company to grow 47% year-on-year, on average, which signals high confidence from analysts. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.

earnings-per-share-growth
NasdaqGS:MMED Earnings Per Share Growth October 26th 2026

Underlying developments driving MiniMed Group's growth isn’t the focus of this broad overview, though, keep in mind that generally a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.

See our latest analysis for MiniMed Group

One thing we’d like to point out is that MiniMed Group has no debt on its balance sheet, which is rare for a loss-making growth company, which typically has high debt relative to its equity. The company currently operates purely off its shareholder funding and has no debt obligation, reducing concerns around repayments and making it a less risky investment.

Next Steps:

There are too many aspects of MiniMed Group to cover in one brief article, but the key fundamentals for the company can all be found in one place – MiniMed Group's company page on Simply Wall St. We've also compiled a list of relevant factors you should further examine:

  1. Valuation: What is MiniMed Group worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether MiniMed Group is currently mispriced by the market.
  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on MiniMed Group’s board and the CEO’s background.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.